Identification of SARS-CoV-2 entry inhibitors among already approved drugs
L Yang, R Pei, H Li, X Ma, Y Zhou, F Zhu… - Acta Pharmacologica …, 2021 - nature.com
To discover effective drugs for COVID-19 treatment amongst already clinically approved
drugs, we developed a high throughput screening assay for SARS-CoV-2 virus entry …
drugs, we developed a high throughput screening assay for SARS-CoV-2 virus entry …
Updated approaches against SARS-CoV-2
H Li, Y Zhou, M Zhang, H Wang… - Antimicrobial agents and …, 2020 - Am Soc Microbiol
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …
The origins of COVID‐19 pandemic: A brief overview
YJ Hao, YL Wang, MY Wang, L Zhou… - Transboundary and …, 2022 - Wiley Online Library
The novel coronavirus disease (COVID‐19) outbreak that emerged at the end of 2019 has
now swept the world for more than 2 years, causing immeasurable damage to the lives and …
now swept the world for more than 2 years, causing immeasurable damage to the lives and …
SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus
Abstract Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2 (Severe Acute
Respiratory Syndrome-Coronavirus-2) of the family Coronaviridae, appeared in China in …
Respiratory Syndrome-Coronavirus-2) of the family Coronaviridae, appeared in China in …
[HTML][HTML] The origins of SARS-CoV-2: A critical review
Since the first reports of a novel severe acute respiratory syndrome (SARS)-like coronavirus
in December 2019 in Wuhan, China, there has been intense interest in understanding how …
in December 2019 in Wuhan, China, there has been intense interest in understanding how …
Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) recently caused a
pandemic outbreak called coronavirus disease 2019 (COVID-19). This disease has initially …
pandemic outbreak called coronavirus disease 2019 (COVID-19). This disease has initially …
Repurposing drugs, ongoing vaccine, and new therapeutic development initiatives against COVID-19
As the COVID-19 is still growing throughout the globe, a thorough investigation into the
specific immunopathology of SARS-CoV-2, its interaction with the host immune system and …
specific immunopathology of SARS-CoV-2, its interaction with the host immune system and …
Chemistry and biology of SARS-CoV-2
A Dömling, L Gao - Chem, 2020 - cell.com
Summary SARS-CoV-2 (previously 2019-nCoV or Wuhan coronavirus) caused an
unprecedented fast-spreading worldwide pandemic. Although currently with a rather low …
unprecedented fast-spreading worldwide pandemic. Although currently with a rather low …
[HTML][HTML] Approaches towards fighting the COVID‑19 pandemic
Abstract The coronavirus disease 2019 (COVID‑19) outbreak, which has caused> 46
millions confirmed infections and> 1.2 million coronavirus related deaths, is one of the most …
millions confirmed infections and> 1.2 million coronavirus related deaths, is one of the most …
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses
Z Zhu, X Lian, X Su, W Wu, GA Marraro, Y Zeng - Respiratory research, 2020 - Springer
Within two decades, there have emerged three highly pathogenic and deadly human
coronaviruses, namely SARS-CoV, MERS-CoV and SARS-CoV-2. The economic burden …
coronaviruses, namely SARS-CoV, MERS-CoV and SARS-CoV-2. The economic burden …